The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes
Abstract
Direct genomic sequencing revealed that cytosine residues known to have undergone a germ-line mutation in the low density lipoprotein receptor gene or somatic mutations in the p53 tumor suppressor gene were methylated in all normal human tissues analyzed. Thus, these mutations should be scored as transitions from 5-methylcytosine to thymine rather than from cytosine to thymine. Methylated cytosines occur exclusively at CpG dinucleotides, which, although markedly underrepresented in human DNA, are sites for more than 30 percent of all known disease-related point mutations. Thus, 5-methylcytosine functions as an endogenous mutagen and carcinogen in humans, in that methylation seems to increase the potential for mutation at cytosine residues at least by a factor of 10.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
Molecular basis of base substitution hotspots in Escherichia coli
Coulondre, C., Miller, J. H., Farabaugh, P. J., & Gilbert, W. (1978) · Nature · doi:10.1038/274775a0 · Cited by 1,193
DNA METHYLATION AND GENE ACTIVITY
Doerfler, W. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.000521 · Cited by 1,098
Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
Ehrlich, M., Gama-Sosa, M. A., Huang, L.-H., Midgett, R. M., Kuo, K. C., McCune, R. A., & Gehrke, C. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.8.2709 · Cited by 1,040
In Vivo Footprinting of a Muscle Specific Enhancer by Ligation Mediated PCR
Mueller, P. R., & Wold, B. (1989) · Science · doi:10.1126/science.2814500 · Cited by 944
The CpG dinucleotide and human genetic disease
Cooper, D. N., & Youssoufian, H. (1988) · Human Genetics · doi:10.1007/bf00278187 · Cited by 931
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Restriction sites containing CpG show a higher frequency of polymorphism in human DNA
BARKER, D., SCHAFER, M., & WHITE, R. (1984) · Cell · doi:10.1016/0092-8674(84)90081-3 · Cited by 573
Cited by
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Self-citationInstability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationGene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Self-citationThe Role of DNA Methylation in Mammalian Epigenetics
Jones, P. A., & Takai, D. (2001) · Science · doi:10.1126/science.1063852 · Cited by 2,070
Self-citationDNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
APC mutations occur early during colorectal tumorigenesis
Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., & Kinzler, K. W. (1992) · Nature · doi:10.1038/359235a0 · Cited by 1,924
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors
Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., et al. (1991) · Science · doi:10.1126/science.1948068 · Cited by 1,234
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Self-citationCancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
Self-citationTargeting the cancer epigenome for therapy
Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.93 · Cited by 1,128
Self-citationTargeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Endogenous DNA damage in humans: a review of quantitative data
De Bont, R. (2004) · Mutagenesis · doi:10.1093/mutage/geh025 · Cited by 1,058
DNA methylation in health and disease
Robertson, K. D., & Wolffe, A. P. (2000) · Nature Reviews Genetics · doi:10.1038/35049533 · Cited by 1,057
Ohshima, H., & Bartsch, H. (1994) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,055
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements
Yang, A. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh032 · Cited by 1,033
Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome
Kim, T. H., Abdullaev, Z. K., Smith, A. D., Ching, K. A., Loukinov, D. I., Green, R. D., Zhang, M. Q., Lobanenkov, V. V., & Ren, B. (2007) · Cell · doi:10.1016/j.cell.2006.12.048 · Cited by 1,033
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Epidemiology and Molecular Pathology of Gallbladder Cancer
Lazcano-Ponce, E. C., Miquel, J. F., Munoz, N., Herrero, R., Ferrecio, C., Wistuba, I. I., Alonso de Ruiz, P., Aristi Urista, G., & Nervi, F. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.6.349 · Cited by 866
DNA glycosylases in the base excision repair of DNA
KROKAN, H. E., STANDAL, R., & SLUPPHAUG, G. (1997) · Biochemical Journal · doi:10.1042/bj3250001 · Cited by 859
Watkins, H., Rosenzweig, A., Hwang, D.-S., Levi, T., McKenna, W., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 747
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Esteller, M., & Herman, J. G. (2002) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 649
The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
Jackson, A. L., & Loeb, L. A. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00091-4 · Cited by 630
DNA methylation: past, present and future directions
Robertson, K. D., & A.Jones, P. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.461 · Cited by 607
Oxidative stress, DNA methylation and carcinogenesis
Franco, R., Schoneveld, O., Georgakilas, A. G., & Panayiotidis, M. I. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.026 · Cited by 603
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
Do, H., & Dobrovic, A. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.223040 · Cited by 572
Mutational processes shape the landscape of TP53 mutations in human cancer
Giacomelli, A. O., Yang, X., Lintner, R. E., McFarland, J. M., Duby, M., Kim, J., Howard, T. P., Takeda, D. Y., Ly, S. H., Kim, E., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0204-y · Cited by 556
Folate and carcinogenesis: evidence, mechanisms, and implications
Kim, Y. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(98)00074-6 · Cited by 554
Epigenetic therapy in immune-oncology
Jones, P. A., Ohtani, H., Chakravarthy, A., & De Carvalho, D. D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0109-9 · Cited by 550
Self-citationRett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots
Wan, M., Lee, S. S. J., Zhang, X., Houwink-Manville, I., Song, H.-R., Amir, R. E., Budden, S., Naidu, S., Pereira, J. L. P., Lo, I. F. M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302690 · Cited by 520
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. (2017) · Nature · doi:10.1038/nature22312 · Cited by 506
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
DNA DAMAGE AND REPAIR IN PLANTS
Britt, A. B. (1996) · Annual Review of Plant Physiology and Plant Molecular Biology · doi:10.1146/annurev.arplant.47.1.75 · Cited by 486
p53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
Harris, C. C. (1993) · Science · doi:10.1126/science.8266092 · Cited by 475
Cancer epigenomics: beyond genomics
Sandoval, J., & Esteller, M. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.008 · Cited by 474
The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA
Shen, J.-C., Rideout, W. M., & Jones, P. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.6.972 · Cited by 457
Self-citationThe DNA (cytosine-5) methyltransferases
Kumar, S., Cheng, X., Klimasauskas, S., Sha, M., Posfai, J., Roberts, R. J., & Wilson, G. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.1.1 · Cited by 429
Momparler, R. L., & Bovenzi, V. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2<145::aid-jcp1>3.0.co;2-v · Cited by 387
5-methylcytosine in RNA: detection, enzymatic formation and biological functions
Motorin, Y., Lyko, F., & Helm, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1117 · Cited by 386
Santhanam, U., Ray, A., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7605 · Cited by 375
van Bokhoven, H., Hamel, B. C. J., Bamshad, M., Sangiorgi, E., Gurrieri, F., Duijf, P. H. G., Vanmolkot, K. R. J., van Beusekom, E., van Beersum, S. E. C., Celli, J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323123 · Cited by 373
Reinisch, K. M., Chen, L., Verdine, G. L., & Lipscomb, W. N. (1995) · Cell · doi:10.1016/0092-8674(95)90060-8 · Cited by 366
GRØNBÆK, K., HOTHER, C., & JONES, P. A. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_636.xml.x · Cited by 366
Self-citationCytosine methylation determines hot spots of DNA damage in the human P 53 gene
Denissenko, M. F., Chen, J. X., Tang, M.-S., & Pfeifer, G. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3893 · Cited by 339
Holliday, R., & Grigg, G. W. (1993) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(93)90052-h · Cited by 336
Richter, S., Vandezande, K., Chen, N., Zhang, K., Sutherland, J., Anderson, J., Han, L., Panton, R., Branco, P., & Gallie, B. (2003) · The American Journal of Human Genetics · doi:10.1086/345651 · Cited by 328
DNA Methylation, Its Mediators and Genome Integrity
Meng, H., Cao, Y., Qin, J., Song, X., Zhang, Q., Shi, Y., & Cao, L. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11218 · Cited by 327
Esteller, M., & Herman, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207316 · Cited by 326
Kim, Y., Pogribny, I., Basnakian, A., Miller, J., Selhub, J., James, S., & Mason, J. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.1.46 · Cited by 326
Karlin, S., Doerfler, W., & Cardon, L. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2889-2897.1994 · Cited by 326
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321
Self-citationHistone deacetylation in epigenetics: An attractive target for anticancer therapy
Mai, A., Massa, S., Rotili, D., Cerbara, I., Valente, S., Pezzi, R., Simeoni, S., & Ragno, R. (2005) · Medicinal Research Reviews · doi:10.1002/med.20024 · Cited by 319
Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis
Dunn, J., Qiu, H., Kim, S., Jjingo, D., Hoffman, R., Kim, C. W., Jang, I., Son, D. J., Kim, D., Pan, C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74792 · Cited by 307
Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
Smith, L. E., Denissenko, M. F., Bennett, W. P., Li, H., Amin, S., Tang, M.-S., & Pfeifer, G. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.803 · Cited by 307
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review
Montesano, R., Holestein, M., & Hainaui, P. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960621)69:3<225::aid-ijc13>3.0.co;2-6 · Cited by 297
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Sadikovic, B., Al-Romaih, K., Squire, J., & Zielenska, M. (2008) · Current Genomics · doi:10.2174/138920208785699580 · Cited by 290
p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk, J., Thor, A. D., Beauchamp, R., Merritt, V, Edgerton, S. M., Bell, D. A., & Yandell, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4961 · Cited by 289
Barnes, D. E., Tomkinson, A. E., Lehmann, A. R., Webster, A. D. B., & Lindahl, T. (1992) · Cell · doi:10.1016/0092-8674(92)90450-q · Cited by 284
Mitra, A. P., Datar, R. H., & Cote, R. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2073 · Cited by 284
High frequency mutagenesis by a DNA methyltransferase
Shen, J.-C., Rideout, W. M., & Jones, P. A. (1992) · Cell · doi:10.1016/s0092-8674(05)80057-1 · Cited by 262
Self-citationMutagenesis at Methylated CpG Sequences
Pfeifer, G. P. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31390-7_10 · Cited by 262
Latronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224
DNA Methylation: a form of epigenetic control of gene expression
Lim, D. H. K., & Maher, E. R. (2010) · The Obstetrician & Gynaecologist · doi:10.1576/toag.12.1.037.27556 · Cited by 155
Epigenetic flexibility in metabolic regulation: disease cause and prevention
Kirchner, H., Osler, M. E., Krook, A., & Zierath, J. R. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.11.008 · Cited by 143
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
Shi, J., Marconett, C. N., Duan, J., Hyland, P. L., Li, P., Wang, Z., Wheeler, W., Zhou, B., Campan, M., Lee, D. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4365 · Cited by 137
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
Pan, F., Wingo, T. S., Zhao, Z., Gao, R., Makishima, H., Qu, G., Lin, L., Yu, M., Ortega, J. R., Wang, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15102 · Cited by 117
Understanding mutagenesis through delineation of mutational signatures in human cancer
Petljak, M., & Alexandrov, L. B. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw055 · Cited by 110
Lee, D.-H., & Pfeifer, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212696200 · Cited by 99
Methylation-Based Therapies for Colorectal Cancer
Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V. (2020) · Cells · doi:10.3390/cells9061540 · Cited by 57
Metadata
- Authors
- Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A.
- Venue
- Science
- Published
- 1990-09-14
- Volume
- 249
- Issue
- 4974
- Pages
- 1288-1290
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2039067014
- Cited by
- 640
- References
- 23
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.